inabl
effect
control
microbi
infect
lead
caus
morbid
mortal
individu
affect
spinal
cord
injuri
sci
avail
evid
clinic
studi
well
anim
model
sci
demonstr
increas
suscept
infect
deriv
disrupt
central
nervou
system
cn
commun
host
immun
system
ultim
lead
immunodepress
understand
molecular
cellular
mechan
govern
mute
cellular
humor
respons
occur
postinjuri
result
impair
host
defens
follow
infect
critic
improv
overal
qualiti
life
individu
sci
review
focus
studi
perform
use
preclin
anim
model
sci
evalu
injuri
impact
b
lymphocyt
respons
follow
either
viral
infect
antigen
challeng
spinal
cord
injuri
sci
dramat
devast
condit
affect
approxim
million
peopl
within
unit
state
asid
vari
sever
motor
skill
impair
sci
result
numer
metabol
immun
problem
last
lifetim
injur
individu
regard
latter
sciinduc
immunodefici
lead
increas
suscept
infect
result
elev
morbid
mortal
year
research
made
effort
character
molecular
cellular
interact
nervou
endocrin
immun
system
facilit
immun
regul
physiolog
homeostasi
earli
find
elucid
mechan
control
import
interplay
system
relat
caus
effect
relationship
inflamm
physiolog
chang
observ
fever
recent
research
describ
suppress
immun
respons
respons
extern
factor
disrupt
neuroendocrinemedi
regul
interact
neural
immun
system
complex
process
involv
bidirect
commun
neurotransmitt
hormon
immun
cellslymphoid
tissu
highlight
lack
autonomi
two
organ
system
understand
multifactori
balanc
immun
regul
continu
grow
interest
especi
field
neurotrauma
research
mani
factor
includ
stroke
traumat
brain
injuri
tbi
sci
known
detriment
effect
immun
system
collect
refer
cn
injuryinduc
immunodepress
cid
follow
stroke
tbi
sci
patient
exhibit
increas
rate
infect
mortal
complic
infect
lead
caus
rehospit
death
postacut
phase
follow
sci
immun
dysfunct
imped
neurolog
recoveri
stroke
patient
evid
support
neuroendocrin
involv
immun
dysfunct
shown
cruse
colleagu
clinic
studi
correl
suppress
immun
function
increas
cortisol
level
patient
sci
therefor
understand
mechan
underli
immunodepress
follow
sci
focu
mani
clinician
research
purpos
improv
therapeut
intervent
qualiti
life
sci
brief
review
articl
focu
sciinduc
deregul
neuroimmun
pathway
provid
perspect
sever
immunodepress
may
influenc
level
sci
specif
focu
primari
adapt
immun
respons
immunolog
memori
impact
follow
sci
within
context
viral
infect
respons
defin
chemic
antigen
cn
provid
network
pathway
regul
inflamm
resolv
infect
maintain
homeostasi
immun
system
modul
cn
via
hypothalomopituitaryadren
axi
hpaa
sympathet
nervou
system
sn
parasympathet
nervou
system
gener
compon
maintain
homeostasi
via
antiinflammatori
mediat
counterbal
inflamm
system
cellular
level
fig
among
variou
effect
immun
system
hpaa
autonom
regul
via
glucocorticoid
catecholamin
cholinerg
signal
respect
target
leukocyt
implic
modul
circul
lymphoid
tissu
cell
number
addit
numer
biolog
function
critic
host
defens
respons
microbi
infect
includ
migrat
prolifer
phagocytosi
cytokin
secret
control
pathway
cell
immun
system
express
receptor
transmitt
reach
cellular
target
via
circul
blood
proxim
nerv
terminalcel
interact
increas
evid
support
vagu
nerv
base
antiinflammatori
pathway
major
data
indic
neuroimmun
interact
domin
sympathet
modul
via
norepinephrin
ne
anatom
studi
map
neuroimmun
pathway
reveal
major
primari
secondari
lymphoid
organ
innerv
sympathet
furthermor
leukocyt
express
adrenerg
receptor
influenc
ne
immun
cell
function
studi
detail
proinflammatori
cytokin
produc
immun
system
respons
stress
injuri
infect
factor
signal
cn
result
immun
modul
activ
hpaa
lead
releas
humor
immunosuppress
glucocorticoid
increas
ne
turnov
rate
spleen
correl
suppress
immun
cell
meltzer
colleagu
show
sn
primarili
respons
immunosuppress
effect
stress
rather
hpaa
use
combin
experiment
splenic
nerv
cut
adrenalectomi
adrenu
demedul
interestingli
activ
sn
inhibit
enhanc
lymphocyt
immun
function
yet
inhibit
function
innat
immun
ne
signal
contribut
cell
develop
subtyp
balanc
associ
immun
respons
durat
time
catecholoamin
exposur
lymphocyt
rel
matur
phase
may
influenc
effector
function
indic
addit
complex
neuroimmun
regul
furthermor
negativefeedback
paradigm
neuroimmun
interact
may
simplifi
nanc
metlzer
argu
cn
output
delay
rel
ongo
immun
reaction
thu
may
instead
provid
greater
influenc
delimit
durat
immun
respons
nonetheless
cn
immun
system
share
counterbal
relationship
disrupt
follow
cnsinjuri
result
injuri
cn
present
uniqu
situat
defin
period
elev
inflamm
within
cn
exacerb
neuropatholog
yet
longlast
impair
regard
control
peripher
microbi
infect
reli
inflamm
order
elimin
invad
pathogen
scenario
ultim
lead
immunodepress
emphas
import
sn
hpaa
pathway
contribut
regul
immun
respons
infect
understand
underpin
involv
immun
deregul
follow
sci
focu
ongo
research
mani
investig
sci
result
physiolog
chang
studi
extens
experiment
clinic
set
sever
locat
injuri
spinal
cord
influenc
outcom
paralysi
muscl
atrophi
loss
sensori
bowel
bladder
sexual
function
may
influenc
degre
immun
suppress
importantli
complic
infect
lead
caus
rehospit
death
postacut
phase
sci
normal
wellbalanc
neuroimmun
interact
disrupt
follow
sci
result
immun
suppress
increas
suscept
infect
despit
immun
suppress
effect
methylprednisolon
acut
scitherapi
immunodepress
increas
sensit
infect
occur
absenc
treatment
therefor
sci
primari
factor
dictat
sever
immun
suppress
sci
interrupt
neural
pathway
involv
neuroimmun
balanc
notabl
central
autonom
pathway
descend
via
spinal
cord
output
signal
preganglion
sympathet
axon
innerv
lymphoid
organ
adren
gland
modul
post
held
sci
although
peripher
nerv
intact
follow
sci
output
peripher
tissu
would
longer
regul
supraspin
control
major
meaning
sn
activ
evolv
thorac
level
innerv
key
lymphoid
tissu
spleen
adren
medulla
aris
midthorac
lumbar
spinal
cord
therefor
sci
level
may
damag
sn
pathway
result
greater
loss
neuroimmun
regul
compar
lower
level
injuri
would
conserv
normal
central
connect
physiolog
process
normal
influenc
sn
blood
pressur
regul
also
experi
leveldepend
chang
follow
sci
reduc
sympathet
activ
morpholog
chang
sympathet
preganaglion
neuron
peripher
alphaadrenoceptor
hyperrespons
observ
follow
loss
supraspin
control
follow
injuri
lead
dynam
chang
cardiovascular
function
time
may
manifest
bout
sympathet
hyperact
ie
autonom
dysreflexia
inde
exagger
catecholamin
releas
episod
automon
dysreflexia
caus
secondari
immun
defici
sci
mous
human
deregul
sn
level
injuri
may
result
dynam
chang
sympathet
activ
modul
immun
function
system
local
lymphoid
tissu
exampl
ne
shown
modul
multipl
compon
immun
respons
includ
express
inhibit
increas
ne
level
signific
increas
ne
level
within
spleen
observ
follow
acut
chronic
injuri
mice
indic
potenti
reduct
proinflammatori
respons
investig
sn
activ
respons
system
administr
lp
follow
high
thorac
injuri
rat
reveal
plasma
level
catecholamin
dramat
reduc
splenic
express
elev
injur
rat
howev
ne
level
within
spleen
unchang
respons
stimul
author
suggest
ne
nerv
fiber
remain
present
within
spleen
signific
amount
ne
releas
respons
stimul
importantli
studi
highlight
need
adequ
method
evalu
sn
activ
within
spleen
use
readout
techniqu
accur
monitor
ne
product
releas
diffus
metabol
transmitt
reuptak
may
chang
time
follow
injuri
final
would
interest
assess
sci
affect
express
adrenerg
receptor
sensit
defin
time
follow
injuri
recent
find
show
express
affin
adrenerg
receptor
lymphocyt
increas
follow
earlyacut
high
thorac
sci
therebi
increas
sensit
glucocorticoid
ne
mediat
immun
suppress
apoptosi
insight
consequ
adrenerg
receptor
chang
lymphocyt
may
gain
futur
vivo
experiment
mous
studi
use
lymphocyt
adopt
transfer
scideriv
leukocyt
uninjur
mice
stimul
immunogen
evalu
cellular
homeostasi
addit
deregul
snsimmun
connect
hpaa
also
contribut
immun
suppress
follow
sci
glucocorticoid
array
effect
modul
innat
adapt
immun
contribut
resolut
inflamm
infect
acut
sci
initi
stress
respons
result
glucocorticoid
product
immun
suppress
absenc
system
inflamm
provid
neg
feedback
hpaa
antiinflammatori
effect
may
compromis
immun
defens
increas
held
suscept
infect
increas
level
glucocorticoid
cortisol
observ
clinic
experiment
sci
rodent
model
cruse
colleagu
correl
invers
relationship
elev
urinefre
cortisol
decreas
cell
function
evalu
express
prolifer
show
immun
function
lowest
month
postinjuri
rodent
sci
model
elev
level
circul
corticosteron
cort
observ
earli
acut
phase
follow
high
low
thorac
injuri
mice
day
postsever
sci
complet
transect
spinal
cord
result
signific
increas
cort
level
compar
surgic
control
moderatecontus
sever
injuri
result
nonsignific
increas
rel
surgic
control
howev
increas
may
transient
other
found
chang
postinjuri
rat
receiv
moderateinjuri
still
other
report
elev
cort
level
day
follow
severeinjuri
exampl
laminectomi
surgic
control
mice
receiv
complet
sci
crushinjuri
elev
plasma
cort
rel
uninjur
mice
day
approxim
one
month
later
mice
injuri
sustain
increas
cort
data
indic
level
sever
sci
may
influenc
outcom
hpaa
activ
durat
potenti
immun
suppress
clinic
experiment
sci
studi
provid
evid
depress
innat
adapt
leukocyt
respons
effect
leukocyt
immun
function
modul
time
follow
sci
mani
case
defici
depend
injuri
level
tabl
provid
overview
immun
compon
modul
postinjuri
relat
level
injuri
tissu
evalu
follow
acut
injuri
dramat
decreas
circul
leukocyt
hladr
mhc
ii
express
observ
h
postinjuri
immun
function
alter
throughout
acut
chronic
injuri
evid
support
pronounc
deficit
observ
injuri
tabl
gener
decreas
leukocyt
number
restor
within
one
week
deficit
cell
effector
function
may
persist
month
indic
system
stress
signal
decentr
lymphoid
tissu
support
leukocyt
contribut
immun
depress
instabl
neuroimmun
interact
follow
sci
complex
adher
respons
stress
lead
period
immun
suppress
observ
autonom
dysreflexia
furthermor
deficit
immun
function
may
also
influenc
sever
injuri
prospect
multicent
clinic
studi
defin
spinal
cord
injuryinduc
immun
depress
syndrom
current
progress
explor
influenci
factor
injurylevel
injuri
sever
monocyt
hladr
express
link
increas
incid
infect
publicaiton
data
studi
anticip
late
find
may
ultim
lead
improv
spinal
cord
injuri
medic
care
adapt
immun
system
play
critic
role
resolv
infect
establish
immunolog
memori
lymphocyt
genesi
number
effector
function
neg
impact
follow
sci
indic
quantit
qualit
decreas
may
contribut
increas
incid
infect
importantli
evid
held
experiment
studi
support
adher
sn
hpaa
signal
postsci
directli
influenc
adapt
immun
exampl
mitogeninduc
cell
prolif
respons
dramat
diminish
month
postinjuri
correl
elev
urinefre
cortisol
level
sci
patient
other
studi
character
intens
level
phase
sci
differenti
alter
function
cell
prolifer
thymusdepend
antibodi
respons
use
innocu
antigen
howev
sci
patient
face
increas
suscept
infect
highlight
need
examin
sci
affect
host
respons
microbi
infect
employ
experiment
sciinfect
model
use
mous
hepat
viru
mhv
antivir
host
defens
mhv
infect
involv
robust
cellmedi
immun
respons
one
week
follow
complet
sci
mice
exhibit
increas
mortal
higher
viral
infect
compar
uninjur
infect
mice
fig
b
increas
sensit
follow
injuri
independ
injuri
level
quantit
differ
cell
splenic
level
follow
infect
injur
mice
antigenpres
cell
activ
viralspecif
cell
number
prolifer
product
significantli
reduc
although
sn
hpaa
activ
evalu
studi
like
elev
splenic
ne
system
cort
exacerb
suppress
antivir
immun
respons
increas
sensit
infect
acut
chronic
stage
postinjuri
fig
increas
evid
support
sciinduc
disrupt
b
cell
humor
function
exampl
increas
b
cell
apoptosi
glucocorticoid
adrenerg
receptor
sensit
observ
acutesci
correl
increas
ne
cort
level
addit
pharmacolog
inhibit
glucocorticoid
adrenerg
receptor
rescu
b
cell
number
humor
activ
b
cell
genesi
also
dramat
affect
follow
acutesci
thu
reduct
cell
surviv
lymphopoiesi
contribut
b
cell
leukopenia
lymphopoiesi
restor
one
month
howev
magnitud
thymusdepend
respons
diminish
follow
sci
greater
deficit
observ
mice
high
thoraciclevel
injuri
interestingli
thymusindepend
type
respons
profoundli
decreas
chronic
injuri
margin
zone
b
cell
critic
thymusindepend
respons
although
inconsist
find
quantit
effect
chronicsci
qualit
fold
reduct
igm
product
increas
sensit
apoptosi
shown
mice
chronic
injuri
find
indic
primari
b
cell
respons
intact
follow
sci
may
contribut
decreas
abil
form
memori
b
cell
longliv
plasma
cell
need
protect
reinfect
secondarychalleng
attempt
address
memori
respons
may
affect
follow
sci
oropallo
colleagu
immun
mice
establish
memori
pool
prior
sci
rechalleng
mice
antigen
fig
strikingli
rest
boost
memori
respons
unchang
frequenc
number
highaffin
splenic
antibodi
secret
cell
concentr
high
affin
antibodi
unalt
follow
high
lowthorac
sci
fig
c
find
reveal
secondari
humor
respons
intact
follow
chronic
sci
therefor
result
suggest
memori
b
cell
may
refractori
neuroimmun
deregul
follow
sci
immun
prior
vaccin
pathogen
remain
unperturb
howev
still
determin
whether
protect
immun
memori
establish
upon
exposur
new
antigen
sci
held
lane
page
semin
immunol
author
manuscript
avail
pmc
septemb
sci
result
lifetim
paralysi
associ
spectrum
medic
complic
includ
metabol
problem
well
increas
suscept
microbi
infect
regard
latter
research
within
clinic
set
well
use
preclin
anim
model
sci
reveal
new
insight
mechan
associ
immunodepress
follow
sci
new
understand
injuri
affect
b
cell
genesi
antibodi
format
memori
respons
character
well
new
inform
injuri
influenc
biolog
antigenpres
cell
subsequ
activ
cell
follow
viral
infect
nonetheless
much
work
need
perform
order
help
individu
sci
combat
control
infect
exampl
effect
sci
innat
immun
respons
follow
infect
eg
pattern
recognit
receptor
prr
need
better
defin
well
character
sci
influenc
host
defens
model
infect
use
clinic
relev
virus
influenza
need
examin
detail
addit
effect
lymphocyt
exhaust
face
infect
need
better
character
final
abil
effect
immun
maintain
stabl
lymphocyt
memori
pool
injur
individu
need
examin
detail
broader
knowledg
injuri
subvert
innat
adapt
immun
respons
face
infect
enabl
clinician
effect
treat
peopl
sci
improv
overal
qualiti
life
neuroimmun
connect
modul
immun
respons
cn
immun
system
interact
balanc
inflammatori
respons
proinflammatori
cytokin
releas
immun
respons
process
cn
result
antiinflammatori
signal
hpaa
sn
activ
hpaa
result
product
glucocorticoid
hormon
gc
catecholamin
ca
system
effect
leukocyt
lymphoid
tissu
activ
sn
result
product
norepinephrin
ne
reach
leukocyt
via
hardwir
connect
lymphoid
tissu
counter
antiinflammatori
respons
cn
interact
system
help
maintain
homeostasi
held
spinal
cord
injur
mice
exhibit
increas
mortal
higher
viral
titer
follow
viral
infect
compar
uninjur
infect
mice
oneweek
postsci
mice
infect
decreas
dosag
mhv
mortal
record
surviv
mice
follow
highest
dosag
mhv
infect
result
mortal
yet
surviv
observ
uninjur
mice
laminectomi
surgerycontrol
mice
surviv
mice
prolong
follow
infect
lower
dosag
b
viral
titer
record
follow
day
postinfect
injur
mice
show
higher
viral
titer
compar
uninjur
mice
follow
infect
oneweek
postsci
plaqu
form
unit
pfu
mice
significantli
higher
titer
compar
uninjur
mice
p
p
respect
four
week
postsci
anoth
cohort
mice
infect
pfu
titer
examin
day
postinfect
mice
significantli
higher
titer
compar
uninjur
mice
p
p
respect
mice
also
significantli
higher
titer
compar
mice
p
surviv
studi
began
mice
infect
group
viral
titer
present
logarithm
mean
pfu
per
gram
liver
shown
column
b
data
point
repres
one
mous
limit
detect
pfug
liver
held
